A new study led by UC San Francisco has found that radiation doses can be safely and effectively reduced – and more consistently administered – for common computed tomography (CT) scans by assessing and comparing doses across hospitals, and then sharing best practices for how much radiation to use.

The National Institute for Health and Care Excellence (NICE) recently issued medical technology guidance recommending the use of Boston Scientific Corp. cardiac resynchronization therapy defibrillators (CRT-D) powered by EnduraLife Battery Technology for treating patients with heart failure.

Vascular Dynamics Inc. (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announces it has completed a $10.4 million financing.

Corindus Vascular Robotics Inc. announced that the first robotic-assisted percutaneous coronary intervention (PCI) procedures were performed in Asia using its CorPath GRX System. One of these procedures was transmitted live from Fu Wai Hospital to the more than 8,000 attendees at the China Interventional Therapeutics Conference. The annual conference, being held in Beijing, China this year, is the largest interventional cardiology conference in the Asia Pacific region.

Biotronik announced the European launch of a new lead for tachycardia therapy that features a helical design for increased long-term performance through stress reduction. The Plexa ProMRI lead is made for use with implantable cardiac defibrillators (ICDs) as well as cardiac resynchronization therapy defibrillators (CRT-Ds).